lncreased risk of slippage upon disengagement of the mitotic checkpoint

PLoS Comput Biol. 2025 Mar 19;21(3):e1012879. doi: 10.1371/journal.pcbi.1012879. eCollection 2025 Mar.

Abstract

Drugs that impair microtubule dynamics alter microtubule-kinetochore attachment and invoke the mitotic checkpoint which arrests cells in mitosis. The arrest can last for hours, but it is leaky: cells adapt (i.e., slip out of it) and exit from mitosis. Here, we investigate the mechanism that allows cells to escape, and whether it is possible to prevent it. Based on a model of the mitotic checkpoint which includes the presence of a positive feedback loop, the escape from the arrest is described as a stochastic transition driven by fluctuations of molecular components from a checkpoint ON to a checkpoint OFF state. According to the model, drug removal further facilitates adaptation, a prediction we confirmed in budding yeast. The model suggests two ways to avoid adaptation: inhibition of APC/C and strengthening the mitotic checkpoint. We confirmed experimentally that both alterations decrease the chance of cells slipping out of mitosis, during a prolonged arrest and after washing out the drug. Our results may be relevant for increasing the efficiency of microtubule depolymerizing drugs.

MeSH terms

  • Computational Biology
  • M Phase Cell Cycle Checkpoints* / drug effects
  • M Phase Cell Cycle Checkpoints* / physiology
  • Microtubules / drug effects
  • Microtubules / metabolism
  • Microtubules / physiology
  • Mitosis* / drug effects
  • Mitosis* / physiology
  • Models, Biological*
  • Saccharomyces cerevisiae

Grants and funding

This work was supported by the italian association for cancer research (AIRC IG grant 28821 to AC); by donations of the Suma-Nesi family; by the Hungarian National Research, Development and Innovation Office (grant TKP2021-EGA-42 to AC); by the unkp-23-1 new national excellence program of the hungarian ministry for culture and innovation, from the source of the national research, development and innovation fund (UNKP-1-I-PPKE-108 to ABS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.